Danai S. Gkotsi
banner
dsgkotsi.bsky.social
Danai S. Gkotsi
@dsgkotsi.bsky.social
R. Fellow in Medicine, Uni of Nottinigham, CBTRC

Self-Assembling Peptide Amphiphile 3D models of the Tumour-Immune Microenvironment of Paediatric Posterior Fossa Tumours.

PhD St Andrews, Goss Group.
Postdoc Astbury Centre, Leeds, Riobo-Del Galdo
Pinned
Really proud to be working on this project with a dream team of experts (Prof. Beth Coyle, Prof. Alvaro Mata, Dr Timothee Ritzmann, Dr Andrew Jackson, Dr Judith Ramage, Dr Ian Kerr and collaborators Prof. Alan McIntyre, Dr Simon Paine, Dr Louise Fetts)

www.childrenwithcancer.org.uk/childhood-ca...
Tumour cells and their environment | Brain tumours | Children with Cancer UK
Dr Beth Coyle and her team are investigating this interaction between tumour cells and their environment. Read more here.
www.childrenwithcancer.org.uk
This is a great PhD opportunity with excellent labs and mentors!
We have a fully funded studentship to start your PhD in October 2026! Work with me, Elton Zeqiraj and Joe Cockburn to find new ways to treat diseases with high levels of Hedgehog signalling. Fantastic training in cell and structural biology, genomic screening and biochemistry at the Uni of Leeds!
Stopping GLI transcription factors in their tracks: identifying regulators of proteolysis as therapeutic targets. at University of Leeds on FindAPhD.com
PhD Project - Stopping GLI transcription factors in their tracks: identifying regulators of proteolysis as therapeutic targets. at University of Leeds, listed on FindAPhD.com
www.findaphd.com
November 10, 2025 at 10:35 AM
Check out our latest study

Precision Molecular Editing: Predicting Substrate Scope and Regiochemistry for CHEESY1, a Flavin Dependent Halogenase | ACS Catalysis pubs.acs.org/doi/10.1021/...
Precision Molecular Editing: Predicting Substrate Scope and Regiochemistry for CHEESY1, a Flavin Dependent Halogenase
The ability to carry out C–H activation at any site on any heteroaromatic scaffold is a holy grail, offering the potential to revolutionize molecule making. Precision editing, activating, and replacin...
pubs.acs.org
November 1, 2025 at 12:13 PM
Precision Molecular Editing: Predicting Substrate Scope and Regiochemistry for CHEESY1, a Flavin Dependent Halogenase | ACS Catalysis pubs.acs.org/doi/10.1021/...

Our newest study just out today!
Precision Molecular Editing: Predicting Substrate Scope and Regiochemistry for CHEESY1, a Flavin Dependent Halogenase
The ability to carry out C–H activation at any site on any heteroaromatic scaffold is a holy grail, offering the potential to revolutionize molecule making. Precision editing, activating, and replacin...
pubs.acs.org
November 1, 2025 at 11:39 AM
Reposted by Danai S. Gkotsi
Cool paper using LLM to discover a protein sequence code for subcellular localization 👏

www.science.org/doi/10.1126/...
Protein codes promote selective subcellular compartmentalization
Cells have evolved mechanisms to distribute ~10 billion protein molecules to subcellular compartments where diverse proteins involved in shared functions must assemble. Here, we demonstrate that prote...
www.science.org
February 9, 2025 at 12:46 AM
Check our group's recent bioelectronic strategy for treating brain tumours. Our study describes a novel approach to overcoming drug resistance by leveraging alternating current (AC) stimulation to enhance drug retention and endosomal escape in aggressive brain tumors. pubs.acs.org/doi/full/10....
Tackling Anticancer Drug Resistance and Endosomal Escape in Aggressive Brain Tumors Using Bioelectronics
Resistance mechanisms in brain tumors, such as medulloblastoma and glioblastoma, frequently involve the entrapment of chemotherapeutic agents within endosomes and the extracellular expulsion of drugs. These barriers to effective treatment are exacerbated in nanotechnology-based drug delivery systems, where therapeutic nanoparticles often remain confined within endosomes, thus diminishing their therapeutic efficacy. Addressing this challenge necessitates the development of novel strategies to enhance the efficiency of cancer therapies. This study tests the hypothesis that external electrical stimuli can modulate intracellular trafficking of chemotherapeutic drugs in common malignant brain tumors in children (medulloblastoma) and adults (glioblastoma) by using gold nanoparticles (GNPs). In our experiments, alternating current (AC) stimulation ranging from 1 kHz to 5 MHz and at a strength of 1 V/cm significantly reduced cell viability in drug-resistant medulloblastoma and enhanced delivery of GNPs in glioblastoma. Low-frequency AC resulted in a 50% increase in apoptosis compared to controls and an 8-fold increase in cell death in cisplatin-resistant medulloblastoma cells, accompanied by a substantial reduction in EC50 from 2.5 to 0.3 μM. Similarly, vincristine-resistant cells demonstrated a 4-fold enhancement in drug sensitivity. Furthermore, high-frequency AC facilitated a significant increase from 20 to 75% in the endosomal escape of GNPs in glioblastoma cells. These findings underscore the potential of AC to selectively disrupt cancer cell resistance mechanisms and bolster the efficacy of nanoparticle-based therapies. The results indicate the effectiveness of AC stimulation in circumventing the limitations inherent in current nanotechnology-based drug delivery systems but also illustrates its transformative potential for treating aggressive, drug-resistant brain tumors.
pubs.acs.org
February 7, 2025 at 9:08 PM
What an incredible line of speakers we had this year at the Cancer Research Nottingham Symposium 2025! I am inspired! And very thankful for this poster award 😍 @uniofnottingham.bsky.social
January 26, 2025 at 2:43 PM
Reposted by Danai S. Gkotsi
If you don’t feel stupid doing science, you’re not trying hard enough.
November 18, 2024 at 4:30 AM
Reposted by Danai S. Gkotsi
As a PI, I consider it to be part of my job to teach trainees how to review respectfully and constructively. You can still recommend rejection of a paper, but there is a polite way to do it. And if the paper is good, for goodness sake, please tell the authors that they did something well!
November 17, 2024 at 3:21 PM
Reposted by Danai S. Gkotsi
Check out the new paper w Alvaro Mata lab led by PhD student Soraya (now Multus Biotech) how to turn whole blood into biomaterials for 3d printing and personalised implants:
onlinelibrary.wiley.com/doi/10.1002/...
Biocooperative Regenerative Materials by Harnessing Blood‐Clotting and Peptide Self‐Assembly
Nature has evolved to repair small fractures by leveraging the cellular and molecular components of regenerative hematoma (RH). This study introduces a biocooperative material approach that enables t...
onlinelibrary.wiley.com
November 16, 2024 at 5:18 PM
Really proud to be working on this project with a dream team of experts (Prof. Beth Coyle, Prof. Alvaro Mata, Dr Timothee Ritzmann, Dr Andrew Jackson, Dr Judith Ramage, Dr Ian Kerr and collaborators Prof. Alan McIntyre, Dr Simon Paine, Dr Louise Fetts)

www.childrenwithcancer.org.uk/childhood-ca...
Tumour cells and their environment | Brain tumours | Children with Cancer UK
Dr Beth Coyle and her team are investigating this interaction between tumour cells and their environment. Read more here.
www.childrenwithcancer.org.uk
November 17, 2024 at 10:23 AM
Reposted by Danai S. Gkotsi
Opportunity to work with #proudofalumni @raflynn5.bsky.social, discoverer of #glycoRNA and breaking all kinds of new ground in cell surface RNA biology
We're looking for a (long term) lab manager (with some wet lab responsibilities) - if anyone knows of a candidate that could be a good fit, please have them email me ryan.flynn@childrens.harvard.edu
November 17, 2024 at 8:06 AM
Reposted by Danai S. Gkotsi
15-year anniversary of discovering PIEZO1 today! Bertrand Coste, then a postdoc in my lab, was knocking down potential mechanosensory ion channels in Neuro2a cells. Candidate 72 yielded a result. Bertrand came into my office and said: ‘I got it!’ — November 13, 2009. A great memory!🧪🧠
November 13, 2024 at 1:46 PM
Reposted by Danai S. Gkotsi
Neat #lipidtime study from @jamessaenz.bsky.social: we have many hundreds of lipids in our membranes, but a minimal cell can survive with just TWO of them: an ether-linked glycerophospholipid and cholesterol. And for the phospholipid, chirality at the glycerol matters! www.nature.com/articles/s41...
November 13, 2024 at 6:06 PM